Drawing for ESCMID EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES

USPTO serial 79127547

ESCMID EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES

Reviewed by CopyMark Law Group

Reg. 4457112Status 709
Filing date
Status date
Registration date
Dec 31, 2013
Examiner
MIDDLETON, BERNICE L
Law office
TMEG LAW OFFICE 106

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ESCMID EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Monica Riva Talley

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.1100 New York Avenue, N.W.Washington, DC 20005UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable specialized electronic publications in the nature of books, journals, magazines, presentations, conference brochures, particularly in the fields of medicine, biomedicine, pharmacy and microbiology; downloadable electronic seminar notes in the fields of medicine, biomedicine, pharmacy and microbiologySECTION 71 - CANCELLED—
016Printed specialized publications, namely, books, journals, magazines, presentations, conference brochures, hand-outs, particularly in the fields of medicine, biomedicine, pharmacy and microbiology; printed seminar notes and printed pamphlets in the fields of medicine, biomedicine, pharmacy and microbiologySECTION 71 - CANCELLED—
035Administrative support, namely, project business management and providing office functions in the organization of events by others, the administration and management of applications for grants and funding, administering study groups, the maintenance of memberships, the organization of observerships for business purposes, and the promotion of scientific journals, all in the field of training, further training and scientific research in the fields of medicine, biomedicine, pharmacy and microbiology; providing academic course, event, traineeship and research fellowship administration services for others, namely, online application and registrationSECTION 71 - CANCELLED—
036Granting of subsidies, namely, providing educational grants, scholarships and fellowships for training and research, particularly in the fields of medicine, biomedicine, pharmacy and microbiology; financial encouragement, namely, providing grants for travel, observership visits and study group development, for training, further training, elaboration of medical guidelines and scientific research, particularly in the fields of medicine, biomedicine, pharmacy and microbiologySECTION 71 - CANCELLED—
041Arranging, organizing, and conducting of educational seminars, symposiums, congresses and conferences, particularly in the fields of medicine, biomedicine, pharmacy and microbiology; Arranging awards program for major scientific contributions, particularly in the fields of medicine, biomedicine, pharmacy and microbiology; providing on-line non-downloadable electronic specialized publications in the nature of books, journals, magazines, presentations, seminar papers, conference brochures in the field of medicine, biomedicine, pharmacy and microbiology, providing on-line non-downloadable electronic seminar notes in the field of medicine, biomedicine, pharmacy and microbiologySECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 6, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 26, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 6, 2026C71TCANCELLED SECTION 71—
Feb 3, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 20, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 14, 2022RNWLINTERNATIONAL REGISTRATION RENEWED—
Jul 6, 2022PRANPOST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED—
Feb 26, 2021ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 24, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 22, 2020EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Dec 20, 2019PR71POST REGISTRATION ACTION MAILED - SEC.71—
Nov 25, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 16, 2019ES71TEAS SECTION 71 RECEIVED—
Jul 22, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 30, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 30, 2014FIMPFINAL DISPOSITION PROCESSED—
Mar 31, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 31, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 15, 2013GPNXNOTIFICATION PROCESSED BY IB—
Oct 15, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 25, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 25, 2013NPUBNOTICE OF PUBLICATION—
Sep 11, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 11, 2013CNEAEXAMINERS AMENDMENT MAILED—
Sep 10, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 10, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Sep 10, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 9, 2013ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 7, 2013PBTQWITHDRAWN FROM PUB OTQR REQUEST—
Aug 28, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 26, 2013ALIEASSIGNED TO LIE—
Aug 16, 2013CNEAEXAMINERS AMENDMENT MAILED—
Aug 16, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 16, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Aug 16, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 5, 2013CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 2, 2013CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 1, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 1, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 1, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 7, 2013RFNTREFUSAL PROCESSED BY IB—
Apr 12, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 12, 2013RFRRREFUSAL PROCESSED BY MPU—
Apr 12, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 11, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 5, 2013DOCKASSIGNED TO EXAMINER—
Apr 5, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 4, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance